Skip to content

Free cash flow at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$8.15B+78.8%
HCA Healthcare logo
HCA HealthcareHCA
$895M+35.6%
National Healthcare logo
National HealthcareNHC
$52.89M+59.7%
Astrana Health logo
Astrana HealthASTH
$64.06M+372%
Tenet Healthcare logo
Tenet HealthcareTHC
Encompass Health Corporation logo
Encompass Health CorporationEHC

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%

Valuation

See full
Market cap$1.9B-49.1%
Enterprise value$6.77B-16.0%
P/S0.6×-0.6×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Calculated from Surgery Partners, Inc.’s reported figures.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s free cash flow?
Surgery Partners, Inc. (SGRY) reported free cash flow of -$4.3M in Q1 2026.
How has Surgery Partners, Inc.'s free cash flow changed year-over-year?
Surgery Partners, Inc.'s free cash flow increased by 74.3% year-over-year, from -$16.7M to -$4.3M.
What is the long-term trend for Surgery Partners, Inc.'s free cash flow?
Over 2 years (2023 to 2025), Surgery Partners, Inc.'s free cash flow has grown at a -2.3% compound annual growth rate (CAGR), from $205M to $195.6M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.